Pricing & Access· August 17, 2026 · 25 min readTavneos on Formularies as FDA Moves to Withdraw: The Coverage DilemmaAs FDA moves to withdraw Tavneos and the EU revokes its approval, the drug remains legally marketed in the US. Here is the coverage...By Ran Chen#Coverage Access#Prior Authorization#Payer Policy
Pricing & Access· May 31, 2026 · 12 min readRenewal denial after stable disease: documenting continued benefitHow access teams can respond to renewal denials after stable disease with evidence of continued benefit, reauthorization...By Ran Chen#Prior Authorization#Reauthorization#Oncology